Landscapes / Targets
BCRP
2 drugs act on BCRP, in 3 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs2
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Cytochrome P450 3A inhibitor |
Gilead (Kite) · Public GILD |
Approved | Jun 2027Phase 4 trial completes | ||
| Next date | Jun 2027 · Phase 4 trial completes | ||||
| Also tested for | Acquired Immune Deficiency Syndrome (AIDS), HIV Infections and 1 more | ||||
| Open drug page | |||||
— |
Approved | Aug 2030Phase 3 trial completes | |||
| Next date | Aug 2030 · Phase 3 trial completes | ||||
| Also tested for | Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 2 and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 2 of 2 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026